ATG7 and chronic myelogenous leukemia, BCR-ABL1 positive: This phenotype was also seen following HCQ treatment, demonstrating that the effect of ATG7 knockdown in our CML model resulted from inhibition of autophagy rather than by affecting autophagy-independent roles of ATG7.